Mr. XiangQian (XQ) Lin is a seasoned global business leader and a synergistic business partner to entrepreneurial scientists and innovators. Having lived and worked across the US, China, Europe, and Singapore, Mr. Lin has accumulated extensive operating and investment experience around the world, building a strong track record in taking technologies from concepts to commercial realities.
Mr. Lin has served as the Chairman and Chief Executive Officer of the Esco Lifesciences Group since 2011, and is a life sciences entrepreneur and investor with a demonstrated track record across the United States, Asia and Europe. In 2018, Mr. Lin served as the founder and managing partner of EVX Ventures, EVX Ventures, a venture capital firm based in Boston/Singapore/Shanghai, builds and invests in biotech companies across Asia and the US. Portfolio companies include Carmine Therapeutics, PairX Bio, Hummingbird Biosciences, Nuevocor, Cargene, Carcell and others. EVX Ventures also invests in US/European biotech companies, bridging them to the Asian markets, especially China and Southeast Asia. EVX incubated companies have closed over USD 1 billion in follow on funding and pharma partnership deals. Mr. Lin holds a B.Sc. degree in Economics and Finance from the Wharton School of Business, University of Pennsylvania.